Fatty Liver/Adipose Tissue Dual-Targeting Nanoparticles with Heme Oxygenase-1 Inducer for Amelioration of Obesity, Obesity-Induced Type 2 Diabetes, and Steatohepatitis
Adv. Sci., First published: 09 October 2022 | https://doi.org/10.1002/advs.202203286
White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes
Biomaterials, Volume 279, December 2021, 121209 | https://doi.org/10.1016/j.biomaterials.2021.121209